FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.9500
-0.0700 (-6.86%)
At close: Mar 28, 2025, 4:00 PM
1.016
+0.066 (6.98%)
After-hours: Mar 28, 2025, 7:55 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $35.28 million as of March 28, 2025. Its market cap has decreased by -90.80% in one year.
Market Cap
35.28M
Enterprise Value
29.02M
1-Year Change
-90.80%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $35.28M, a decrease of -96.27%. That is a compound annual growth rate of -94.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 35.28M | -49.72% |
| Dec 31, 2024 | 70.17M | -92.58% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |